F19.221
Other psychoactive substance dependence with intoxication delirium
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.221 refers to a specific type of substance dependence involving psychoactive substances. This condition is characterized by a combination of ongoing dependence on a psychoactive substance and episodes of intoxication that develop into delirium. Such delirium is a serious state of mental confusion and disorientation, often accompanied by hallucinations, fluctuating consciousness, and potential physical health issues. Recognizing this condition helps in understanding the complexities involved in substance dependence and the importance of proper medical intervention.
Causes & Symptoms
Clinical Causes: Prolonged and excessive use of psychoactive substances such as stimulants, sedatives, opioids, or hallucinogens. Repeated episodes of intoxication leading to alterations in brain chemistry and function. Underlying mental health conditions that may predispose an individual to substance dependence and delirium. Inadequate treatment or withdrawal management for existing substance dependence. Co-occurring medical conditions, such as liver or kidney disease, that can exacerbate the effects of intoxication.
Key Symptoms: Altered mental state with rapid shifts in consciousness. Hallucinations, both visual and auditory. Disorientation and confusion about time, place, or identity. Agitation, restlessness, or aggressive behavior. Physical signs such as tremors, sweating, increased heart rate, or seizures. Fluctuating levels of consciousness, possibly leading to coma in severe cases. Impaired judgment and inability to communicate effectively.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of this condition involves a comprehensive evaluation by healthcare providers, including a clinical history reviewing substance use patterns, the onset and duration of symptoms, and physical examinations. Laboratory tests such as blood and urine screens can detect the presence and levels of specific psychoactive substances. Neuroimaging or neurological assessments may be used to rule out other causes of delirium. The psychiatrist or medical team will also assess for underlying mental health issues and potential withdrawal states.
Treatment Protocols: Treatment strategies focus on managing both the dependence and the acute delirium episodes. Typically, this involves: - Hospitalization for close monitoring and supportive care. - Discontinuation or reduction of the psychoactive substance causing symptoms. - Use of medications to control agitation, psychosis, or seizures, such as antipsychotics or benzodiazepines. - Rehydration and correction of electrolyte imbalances. - Addressing withdrawal symptoms if present, often with tapering doses of the offending substance. - Psychological support and counseling to address underlying dependence and prevent relapse. - Long-term treatment plans, including therapy or rehabilitation programs, for sustained recovery. Effective management requires a multidisciplinary approach involving medical doctors, psychiatrists, and addiction specialists.
Clinical Advice & FAQs
Billing Guidance
Is F19.221 a billable ICD-10 code?
Yes, F19.221 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.221?
Clinical documentation must specify the nature of Other psychoactive substance dependence with intoxication delirium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
